These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34491031)

  • 1. Cyclic Tetrapeptide HDAC Inhibitors with Improved
    Collins JE; Lee JW; Bohmer MJ; Welden JD; Arshadi AK; Du L; Cichewicz RH; Chakrabarti D
    ACS Infect Dis; 2021 Oct; 7(10):2889-2903. PubMed ID: 34491031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites.
    Engel JA; Jones AJ; Avery VM; Sumanadasa SD; Ng SS; Fairlie DP; Skinner-Adams T; Andrews KT
    Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):117-26. PubMed ID: 26199860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stages.
    Hansen FK; Sumanadasa SD; Stenzel K; Duffy S; Meister S; Marek L; Schmetter R; Kuna K; Hamacher A; Mordmüller B; Kassack MU; Winzeler EA; Avery VM; Andrews KT; Kurz T
    Eur J Med Chem; 2014 Jul; 82():204-13. PubMed ID: 24904967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico identification of inhibitors against Plasmodium falciparum histone deacetylase 1 (PfHDAC-1).
    Kumar A; Dhar SK; Subbarao N
    J Mol Model; 2018 Aug; 24(9):232. PubMed ID: 30109440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimalarial histone deacetylase inhibitors containing cinnamate or NSAID components.
    Wheatley NC; Andrews KT; Tran TL; Lucke AJ; Reid RC; Fairlie DP
    Bioorg Med Chem Lett; 2010 Dec; 20(23):7080-4. PubMed ID: 20951583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, antimalarial properties, and SAR studies of alkoxyurea-based HDAC inhibitors.
    Hansen FK; Skinner-Adams TS; Duffy S; Marek L; Sumanadasa SD; Kuna K; Held J; Avery VM; Andrews KT; Kurz T
    ChemMedChem; 2014 Mar; 9(3):665-70. PubMed ID: 24497437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of alkoxyamide-based histone deacetylase inhibitors against Plasmodium falciparum malaria parasites.
    Dawood WA; Fisher GM; Kinnen FJM; Anzenhofer C; Skinner-Adams T; Alves Avelar L; Asfaha Y; Kurz T; Andrews KT
    Exp Parasitol; 2024 Mar; 258():108716. PubMed ID: 38340779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and Synthesis of Novel Anti-Plasmodial Histone Deacetylase Inhibitors Containing an Alkoxyamide Connecting Unit.
    Alves Avelar LA; Held J; Engel JA; Sureechatchaiyan P; Hansen FK; Hamacher A; Kassack MU; Mordmüller B; Andrews KT; Kurz T
    Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28317157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimalarial activity of the anticancer histone deacetylase inhibitor SB939.
    Sumanadasa SD; Goodman CD; Lucke AJ; Skinner-Adams T; Sahama I; Haque A; Do TA; McFadden GI; Fairlie DP; Andrews KT
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3849-56. PubMed ID: 22508312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitors with high in vitro activities against Plasmodium falciparum isolates collected from Gabonese children and adults.
    Koehne E; Kreidenweiss A; Zoleko Manego R; McCall M; Mombo-Ngoma G; Mackwitz MKW; Hansen FK; Held J
    Sci Rep; 2019 Nov; 9(1):17336. PubMed ID: 31758015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in mice.
    Chua MJ; Tng J; Hesping E; Fisher GM; Goodman CD; Skinner-Adams T; Do D; Lucke AJ; Reid RC; Fairlie DP; Andrews KT
    Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():118-127. PubMed ID: 34560571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors.
    Tavares MT; Krüger A; Yan SLR; Waitman KB; Gomes VM; de Oliveira DS; Paz F; Hilscher S; Schutkowski M; Sippl W; Ruiz C; Toledo MFZJ; Hassimotto NMA; Machado-Neto JA; Poso A; Cameron MD; Bannister TD; Palmisano G; Wrenger C; Kronenberger T; Parise-Filho R
    Sci Rep; 2023 Nov; 13(1):21006. PubMed ID: 38030668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of FNDR-20123, a histone deacetylase inhibitor for the treatment of Plasmodium falciparum malaria.
    Potluri V; Shandil RK; Gavara R; Sambasivam G; Campo B; Wittlin S; Narayanan S
    Malar J; 2020 Oct; 19(1):365. PubMed ID: 33046062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysine acetylation in sexual stage malaria parasites is a target for antimalarial small molecules.
    Trenholme K; Marek L; Duffy S; Pradel G; Fisher G; Hansen FK; Skinner-Adams TS; Butterworth A; Ngwa CJ; Moecking J; Goodman CD; McFadden GI; Sumanadasa SD; Fairlie DP; Avery VM; Kurz T; Andrews KT
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3666-78. PubMed ID: 24733477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and Synthesis of Terephthalic Acid-Based Histone Deacetylase Inhibitors with Dual-Stage Anti-Plasmodium Activity.
    Stenzel K; Chua MJ; Duffy S; Antonova-Koch Y; Meister S; Hamacher A; Kassack MU; Winzeler E; Avery VM; Kurz T; Andrews KT; Hansen FK
    ChemMedChem; 2017 Oct; 12(19):1627-1636. PubMed ID: 28812327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimalarial activity of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors.
    Dow GS; Chen Y; Andrews KT; Caridha D; Gerena L; Gettayacamin M; Johnson J; Li Q; Melendez V; Obaldia N; Tran TN; Kozikowski AP
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3467-77. PubMed ID: 18644969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent antimalarial activity of histone deacetylase inhibitor analogues.
    Andrews KT; Tran TN; Lucke AJ; Kahnberg P; Le GT; Boyle GM; Gardiner DL; Skinner-Adams TS; Fairlie DP
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1454-61. PubMed ID: 18212103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QSAR Classification Models for Prediction of Hydroxamate Histone Deacetylase Inhibitor Activity against Malaria Parasites.
    Hesping E; Chua MJ; Pflieger M; Qian Y; Dong L; Bachu P; Liu L; Kurz T; Fisher GM; Skinner-Adams TS; Reid RC; Fairlie DP; Andrews KT; Gorse AJP
    ACS Infect Dis; 2022 Jan; 8(1):106-117. PubMed ID: 34985259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of thiaheterocyclic hHDAC6 inhibitors as potential antiplasmodial agents.
    Vreese R; Kock C; Smith PJ; Chibale K; D'hooghe M
    Future Med Chem; 2017 Mar; 9(4):357-364. PubMed ID: 28263085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. vivax.
    Marfurt J; Chalfein F; Prayoga P; Wabiser F; Kenangalem E; Piera KA; Fairlie DP; Tjitra E; Anstey NM; Andrews KT; Price RN
    Antimicrob Agents Chemother; 2011 Mar; 55(3):961-6. PubMed ID: 21135175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.